aprofen has been researched along with Neuroblastoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, P; Ahmad, A; Carroll, FI; Chiang, PK; Griffith, RC; Padilla, FN; Parham, K; Richard, MM; Witkin, JM | 1 |
| Chiang, PK; Doctor, BP; Gordon, RK; Moore, E; Padilla, FN | 1 |
| Aarbakke, J; Brown, ND; Chiang, PK; Doctor, BP; Gordon, RK; Gray, RR; Miura, GA | 1 |
3 other study(ies) available for aprofen and Neuroblastoma
| Article | Year |
|---|---|
6-Methyl-6-azabicyclo[3.2.1]octan-3 alpha-ol 2,2-diphenylpropionate (azaprophen), a highly potent antimuscarinic agent.
Topics: Acetylcholine; alpha-Amylases; Animals; Behavior, Animal; Carbachol; Cell Line; Chemical Phenomena; Chemistry; Guinea Pigs; Humans; Male; Molecular Conformation; Muscle Contraction; Neuroblastoma; Pancreas; Phenylpropionates; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Scopolamine; Tropanes | 1987 |
Antimuscarinic activity of aprophen.
Topics: Animals; Cell Line; Cells, Cultured; Glioma; Hybrid Cells; Kinetics; Liver; Mice; Muscles; Neuroblastoma; Parasympatholytics; Phenylpropionates; Quinuclidinyl Benzilate; Rats; Receptors, Muscarinic | 1983 |
Disposition of aprophen in rats.
Topics: Animals; Cells, Cultured; Hydrolysis; Kinetics; Male; Nervous System Neoplasms; Neuroblastoma; Parasympatholytics; Phenylpropionates; Rats; Rats, Inbred Strains; Tissue Distribution | 1986 |